Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles
One potential approach for the treatment of Duchenne muscular dysrophy is to increase expression of the dystrophin homolog utrophin. Here, the authors show that eEF1A2 regulates utrophin expression, and show that 2 FDA-approved drugs upregulate eEIF1A2 and utrophin level in mice, leading to improvem...
Main Authors: | Christine Péladeau, Nadine Adam, Lucas M. Bronicki, Adèle Coriati, Mohamed Thabet, Hasanen Al-Rewashdy, Jason Vanstone, Alan Mears, Jean-Marc Renaud, Martin Holcik, Bernard J. Jasmin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15971-w |
Similar Items
-
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
by: Kennedy, T, et al.
Published: (2017) -
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
by: Tahnee L. Kennedy, et al.
Published: (2017-10-01) -
IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.
by: Pedro Miura, et al.
Published: (2008-01-01) -
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by: Wakefield, P, et al.
Published: (2000) -
On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective Outfits
by: Alberto Mills, et al.
Published: (2021-06-01)